Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 65 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Intraventricular Brain Hemorrhage Clear all

Conditions: Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage, Stroke, Cerebrovascular Disease
Interventions: Reversal of Oral anticoagulation within 30 minutes, Early intensive blood pressure lowering, Treatment of pyrexia, Hyperglycemia treatment, Do-not-resuscitate (DNR) or withdrawal of care, Referral to Intensive Care, Referral to Neurosurgery, Repeat brain imaging, Standard care; Other · Diagnostic Test
Lead sponsor: Region Skane; Other
Eligibility: 18 Years and older
Enrollment: 3,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Intraventricular Hemorrhage
Interventions: Alteplase, Normal saline; Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 52
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 39 more

Conditions: Intraventricular Hemorrhage, Subarachnoid Hemorrhage
Interventions: Bactiseal TM EVD, Standard EVD Catheter; Device
Lead sponsor: Codman & Shurtleff; Industry
Eligibility: 18 Years and older
Enrollment: 434 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 4
States / cities: Los Angeles, California • Gainesville, Florida • Syracuse, New York + 1 more

Conditions: Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
Interventions: OHB-607; Drug
Lead sponsor: OHB Neonatology Ltd.; Industry
Eligibility: 0 Hours to 24 Hours
Enrollment: 295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 24
States / cities: Little Rock, Arkansas • California City, California • Los Angeles, California + 19 more

Conditions: Cerebral Palsy, Intraventricular Hemorrhage, Periventricular Leukomalacia, Pulmonary Edema, Abruptio Placentae
Interventions: magnesium sulfate; Drug
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: Female only
Enrollment: 2,136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 17
States / cities: Birmingham, Alabama • Miami, Florida • Chicago, Illinois + 14 more

Conditions: Prematurity, Bronchopulmonary Dysplasia, Intraventricular Hemorrhage, Periventricular Leukomalacia
Interventions: inhaled nitric oxide, oxygen; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 2 Hours to 72 Hours
Enrollment: 273 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Infant, Newborn, Infant, Small for Gestational Age, Infant, Very Low Birth Weight, Infant, Premature, Intracranial Hemorrhages
Interventions: Vitamin E, Placebo; Drug
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 4 Hours
Enrollment: 93 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 16
States / cities: Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 12 more

Conditions: Infant, Premature, Erythropoietin, Brain Injury, Intraventricular Hemorrhage, Periventricular Leukomalacia, Neurodevelopmental Outcomes, Randomized Clinical Trial
Interventions: Erythropoietin, Saline placebo; Drug
Lead sponsor: Atlantic Health System; Other
Eligibility: Up to 24 Hours
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Premature Infants
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 7 Days
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Infant, Very Low Birth Weight, Infant, Premature, Diseases, Cerebral Hemorrhage
Interventions: Not listed
Lead sponsor: University of Arkansas; Other
Eligibility: 1 Hour to 7 Days
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2008
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Intraventricular Hemorrhage, Subarachnoid Hemorrhage
Interventions: CerebroFlo™ EVD Catheter; Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 10
States / cities: Loma Linda, California • Palo Alto, California • Aurora, Colorado + 7 more

Conditions: Intraventricular Hemorrhage of Prematurity, Complications of Prematurity
Interventions: NIRS monitoring; Device
Lead sponsor: Stanford University; Other
Eligibility: Up to 24 Hours
Enrollment: 111 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 7
States / cities: Birmingham, Alabama • Palo Alto, California • San Jose, California + 4 more

Conditions: Motor Delay, Premature Birth, Intraventricular Hemorrhage, Hypoxic-Ischemic Encephalopathy, Bronchopulmonary Dysplasia
Interventions: Physical Therapy intervention; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 33 Weeks to 48 Weeks
Enrollment: 222 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 3
States / cities: Chicago, Illinois

Conditions: Apnea of Prematurity, Intraventricular Hemorrhage, Brain Injury
Interventions: Caffeine citrate; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 24 Weeks to 30 Weeks
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cerebral Hemorrhage
Interventions: Recombinant Tissue Plasminogen Activator (rt-PA); Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Intraventricular Hemorrhage, Periventricular Leukomalacia, Brain Injury, Renal Injury
Interventions: Indomethacin, delay in umbilical cord clamp at birth, placebo infusion, immediate cord clamp at birth; Drug · Procedure
Lead sponsor: Hong Huang; Other
Eligibility: 24 Weeks to 30 Weeks
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Post-Hemorrhagic Hydrocephalus
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: Up to 180 Days
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • St Louis, Missouri • Pittsburgh, Pennsylvania + 3 more

Conditions: Preterm Less Than 32wks With IVH, WMI/PVL, Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE
Interventions: Prospective Clinical and Neurodevelopmental Data Collection; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 31 Weeks to 42 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intraventricular Hemorrhage, Spina Bifida
Interventions: collection of CSF and blood; Genetic
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: Up to 6 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Intraventricular Haemorrhage Neonatal, Death; Neonatal
Interventions: Umbilical cord milking UCM, Delayed cord clamping DCC; Procedure
Lead sponsor: Sharp HealthCare; Other
Eligibility: 23 Weeks to 33 Weeks
Enrollment: 1,201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 15
States / cities: Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 10 more

Conditions: Intraventricular Hemorrhage
Interventions: tissue plasminogen activator, rt-PA (thrombolytic) (Cathflo); Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 22
States / cities: Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 17 more

Conditions: Intraventricular Hemorrhage
Interventions: Therapy BRIDGE Program; Other
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Intraventricular Hemorrhage, Late Onset Neonatal Sepsis, Motor Skills Disorders
Interventions: delayed cord clamping; Procedure
Lead sponsor: University of Rhode Island; Other
Eligibility: Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Intraventricular Hemorrhage, Periventricular Leukomalacia, Brain Injury, Extreme Prematurity
Interventions: Brain Monitoring Platform; Other
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 0 Hours to 12 Hours
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 3
States / cities: Houston, Texas

Search by objective public record fields.

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III

Comparative Infection Rates for the Codman BACTISEAL TM External Ventricular Drainage (EVD) System

A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants

Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Vitamin E for Extremely Preterm Infants

High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study

Urine Concentration of S100B in Extremely Premature Infants

Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants

The Purpose of This Study is to Determine Whether CerebroFlo™ EVD Catheter is Effective During the Treatment of Intraventricular Hemorrhage (IVH)

Cerebral Oxygenation and Autoregulation in Preterm Infants

Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit

MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury

Shunt Outcomes of Post-Hemorrhagic Hydrocephalus

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)

Premature Infants Receiving Milking or Delayed Cord Clamping: PREMOD2

Clinical Trial on Treatment of Intraventricular Hemorrhage

Therapy BRIDGE (Bringing Real-Time Instruction Via Developmental and Gestationally-appropriate Education/Coaching) Program: A Pilot Study

Effects of Delayed Cord Clamping in Very Low Birth Weight Infants

Prediction of Brain Injury in Premature Infants